Partial chemical characterization of cyclopyrrolones ([3H] suriclone) and benzodiazepines ([3H]flunitrazepam) binding site: differences
- PMID: 2987639
- DOI: 10.1016/0024-3205(85)90336-4
Partial chemical characterization of cyclopyrrolones ([3H] suriclone) and benzodiazepines ([3H]flunitrazepam) binding site: differences
Abstract
Rat hippocampus membranes were treated with several protein modifying reagents (iodoacetamide, N-ethylmaleimide, tetranitromethane and N-acetylimidazole). The effects of these treatments on the binding sites of cyclopyrrolones ([3H] suriclone), a new chemical family of minor tranquilizers, and benzodiazepines ([3H] flunitrazepam) were investigated. Here we show that both ligands are similarly sensitive to cysteine alkylation: [3H] suriclone and [3H] flunitrazepam binding are reduced by iodoacetamide and slightly increased by N-ethylmaleimide. On the contrary they are clearly differenciated by tyrosine modification: [3H] suriclone binding is not changed whereas [3H] flunitrazepam binding is increased by tetranitromethane and decreased by N-acetylimidazole. Our present findings and published evidence suggest cyclopyrrolones and benzodiazepines bind to distinct sites or to different allosteric forms of the benzodiazepine receptor.
Similar articles
-
Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.Mol Pharmacol. 1984 Nov;26(3):458-69. Mol Pharmacol. 1984. PMID: 6092896
-
The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines.Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep;350(3):294-300. doi: 10.1007/BF00175035. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7824046
-
Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepine binding to rat hippocampus photolabelled membranes.Biochem Pharmacol. 1983 Dec 1;32(23):3651-3. doi: 10.1016/0006-2952(83)90318-0. Biochem Pharmacol. 1983. PMID: 6316990 No abstract available.
-
Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum.J Neurochem. 1983 Mar;40(3):601-7. doi: 10.1111/j.1471-4159.1983.tb08023.x. J Neurochem. 1983. PMID: 6298365
-
Benzodiazepine binding to GABAA receptors: differential effects of sulfhydryl modification.Eur J Pharmacol. 1993 Jul 15;246(2):141-8. doi: 10.1016/0922-4106(93)90091-m. Eur J Pharmacol. 1993. PMID: 8397093
Cited by
-
Suriclone and diazepam in the treatment of neurotic anxiety. A double-blind cross-over trial.Psychopharmacology (Berl). 1987;93(3):296-300. doi: 10.1007/BF00187246. Psychopharmacology (Berl). 1987. PMID: 2893410 Clinical Trial.
-
Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.Eur J Clin Pharmacol. 1995;49(3):183-91. doi: 10.1007/BF00192378. Eur J Clin Pharmacol. 1995. PMID: 8665994 Clinical Trial.
-
Sleep laboratory studies on single dose effects of suriclone.Br J Clin Pharmacol. 1990 Nov;30(5):703-10. doi: 10.1111/j.1365-2125.1990.tb03839.x. Br J Clin Pharmacol. 1990. PMID: 1980201 Free PMC article. Clinical Trial.
-
Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.Psychopharmacology (Berl). 1991;104(4):439-43. doi: 10.1007/BF02245646. Psychopharmacology (Berl). 1991. PMID: 1685793 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical